NO158422C - Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater. - Google Patents

Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater.

Info

Publication number
NO158422C
NO158422C NO814359A NO814359A NO158422C NO 158422 C NO158422 C NO 158422C NO 814359 A NO814359 A NO 814359A NO 814359 A NO814359 A NO 814359A NO 158422 C NO158422 C NO 158422C
Authority
NO
Norway
Prior art keywords
preparation
new
analogy procedure
oxadiazolopyrimidine derivatives
oxadiazolopyrimidine
Prior art date
Application number
NO814359A
Other languages
English (en)
Norwegian (no)
Other versions
NO158422B (no
NO814359L (no
Inventor
Urs Hengartner
Henri Ramuz
Jean-Claude Muller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO814359L publication Critical patent/NO814359L/no
Publication of NO158422B publication Critical patent/NO158422B/no
Publication of NO158422C publication Critical patent/NO158422C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO814359A 1980-12-19 1981-12-18 Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater. NO158422C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH941080 1980-12-19
CH635081 1981-10-02

Publications (3)

Publication Number Publication Date
NO814359L NO814359L (no) 1982-06-21
NO158422B NO158422B (no) 1988-05-30
NO158422C true NO158422C (no) 1988-09-07

Family

ID=25699419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO814359A NO158422C (no) 1980-12-19 1981-12-18 Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater.

Country Status (23)

Country Link
US (2) US4410698A (ko)
EP (1) EP0054866B1 (ko)
KR (1) KR880001636B1 (ko)
AR (1) AR229169A1 (ko)
AT (1) ATE14734T1 (ko)
AU (1) AU545324B2 (ko)
BR (1) BR8108269A (ko)
CA (1) CA1162538A (ko)
CS (1) CS226738B2 (ko)
DE (1) DE3171744D1 (ko)
DK (1) DK148826C (ko)
ES (1) ES8304125A1 (ko)
FI (1) FI71153C (ko)
GR (1) GR76969B (ko)
HU (1) HU183744B (ko)
IE (1) IE51800B1 (ko)
IL (1) IL64524A (ko)
MC (1) MC1438A1 (ko)
NO (1) NO158422C (ko)
NZ (1) NZ199250A (ko)
PH (1) PH17300A (ko)
PT (1) PT74153B (ko)
ZW (1) ZW28581A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade
CH649291A5 (de) * 1982-03-16 1985-05-15 Hoffmann La Roche Dicarbamate.
EP0187854A4 (en) * 1984-07-13 1987-01-22 Gail S Bazzano SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR PROMOTING HAIR GROWTH.
LU86959A1 (fr) * 1987-07-31 1989-03-08 Oreal Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
DE69715869T2 (de) * 1996-07-26 2003-05-28 Vantico Ag, Basel Auf epoxyharzen basierende imidazole enthaltende härtbare mischungen
CN117946133B (zh) * 2024-01-05 2024-08-06 南京理工大学 一种5-(4-氨基-1,2,5-噁二唑-3-基)[1,2,5]噁二唑并[3,4-d]嘧啶-7-胺及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638215A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-derivate.
CH638216A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-deriate.
CA1103245A (en) * 1978-07-21 1981-06-16 Jean-Claude Muller Process for the manufacture of novel oxadiazolopyrimidine derivatives
NZ190915A (en) * 1978-07-31 1984-07-31 Hoffmann La Roche Oxadiazolotriazine derivatives and pharmaceutical compositions
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade

Also Published As

Publication number Publication date
FI71153B (fi) 1986-08-14
ZW28581A1 (en) 1982-08-11
DK504881A (da) 1982-06-20
AU545324B2 (en) 1985-07-11
FI814048L (fi) 1982-06-20
IL64524A0 (en) 1982-03-31
EP0054866B1 (de) 1985-08-07
ATE14734T1 (de) 1985-08-15
ES508152A0 (es) 1983-02-16
HU183744B (en) 1984-05-28
AU7846481A (en) 1982-06-24
US4360521A (en) 1982-11-23
FI71153C (fi) 1986-11-24
ES8304125A1 (es) 1983-02-16
DE3171744D1 (en) 1985-09-12
NZ199250A (en) 1984-04-27
EP0054866A3 (en) 1982-09-01
PT74153B (en) 1984-01-05
US4410698A (en) 1983-10-18
IE812990L (en) 1982-06-19
IE51800B1 (en) 1987-04-01
AR229169A1 (es) 1983-06-30
CA1162538A (en) 1984-02-21
IL64524A (en) 1985-05-31
GR76969B (ko) 1984-09-04
PT74153A (en) 1982-01-01
DK148826B (da) 1985-10-14
PH17300A (en) 1984-07-18
EP0054866A2 (de) 1982-06-30
CS226738B2 (en) 1984-04-16
BR8108269A (pt) 1982-10-05
DK148826C (da) 1986-03-24
NO158422B (no) 1988-05-30
MC1438A1 (fr) 1982-12-06
NO814359L (no) 1982-06-21
KR880001636B1 (ko) 1988-09-03

Similar Documents

Publication Publication Date Title
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO794327L (no) Fremgangsmaate ved fremstilling av nye peptidylargininaldehyd-derivater.
NO160780C (no) Analogifremgangsmaate ved fremstilling av substituerte iminodisyrer.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO800650L (no) Fremgangsmaate ved fremstilling av nye indolderivater
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
NO156828B (no) Analogifremgangsmaate for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO155885C (no) Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO803935L (no) Fremgangsmaate ved fremstilling av nye 2-acylaminomethyl-1,4-benzodiazepiner
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO800338L (no) Fremgangsmaate ved fremstilling av nye 4-(nafthylmethyl)piperidinderivater.
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO158743C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser.
NO802402L (no) R fremgangsmaate ved fremstilling av nye halovincamonderivate
NO833521L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme vinylthioacetamido-oxacefalosporinderivater
NO158422C (no) Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater.
NO803044L (no) Fremgangsmaate ved fremstilling av nye derivater av 1,2,4-oxadiazolin-5-on
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO157864C (no) Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater.
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater